Treatment Of Myasthenia Gravis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
IMVT | F | Immunovant, Inc. | 0.44 | |
GTBP | C | GT Biopharma, Inc. | 1.02 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Myasthenia Gravis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | B | ALPS Medical Breakthroughs ETF | 2.93 | |
MNTL | D | Tema Neuroscience and Mental Health ETF | 1.49 | |
BBC | B | Virtus LifeSci Biotech Clinical Trials ETF | 0.9 | |
XBI | B | SPDR S&P Biotech ETF | 0.7 | |
NSCS | B | Nuveen Small Cap Select ETF | 0.48 |
Compare ETFs
Related Industries:
Biotechnology
- Treatment Of Myasthenia Gravis
Treatment of myasthenia gravis typically involves medications, such as cholinesterase inhibitors, immunosuppressants, and corticosteroids, as well as other therapies, such as plasmapheresis and thymectomy. The goal of treatment is to reduce the severity of symptoms and improve the patient's quality of life.
Popular Now
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles